Michel G D Kester

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Stem Cell Transplantation

Prognostic Factors

High Throughput Sequencing

Top Venues

Cancer immunology, immunotherapy : CII

Cellular and molecular life sciences : CMLS

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Kyra J Fuchs, Marian van de Meent, M Willy Honders, Indu Khatri, Michel G D Kester, Eva A S Koster, Georgia Koutsoumpli, Arnoud H de Ru, Cornelis A M van Bergen, Peter A van Veelen, Peter A C 't Hoen, Peter van Balen, Erik Ben van den Akker, Joan Hendrik Veelken, Constantijn Jm Jm Halkes, J H Frederik Falkenburg, Marieke Griffioen
Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens. Blood 143 (18) (2024)
Kyra J Fuchs, Marian van de Meent, Maria W Honders, Indu Khatri, Michel G D Kester, Eva A S Koster, Georgia Koutsoumpli, Arnoud H de Ru, Cornelis A M van Bergen, Peter A van Veelen, Peter A C 't Hoen, Peter van Balen, Erik Ben van den Akker, Hendrik Veelken, Constantijn Jm Jm Halkes, J H Frederik Falkenburg, Marieke Griffioen
Expanding the repertoire reveals recurrent, cryptic and hematopoietic HLA class I minor histocompatibility antigens. Blood (2024)
Kyra J Fuchs, Marian van de Meent, M Willy Honders, Indu Khatri, Michel G D Kester, Eva A S Koster, Georgia Koutsoumpli, Arnoud H de Ru, Cornelis A M van Bergen, Peter A van Veelen, Peter A C 't Hoen, Peter van Balen, Erik Ben van den Akker, Joan Hendrik Veelken, Constantijn Jm Jm Halkes, J H Frederik Falkenburg, Marieke Griffioen
Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens. Blood 143 (18) (2024)
Kyra J Fuchs, Marian van de Meent, Maria W Honders, Indu Khatri, Michel G D Kester, Eva A S Koster, Georgia Koutsoumpli, Arnoud H de Ru, Cornelis A M van Bergen, Peter A van Veelen, Peter A C 't Hoen, Peter van Balen, Erik Ben van den Akker, Hendrik Veelken, Constantijn Jm Jm Halkes, J H Frederik Falkenburg, Marieke Griffioen
Expanding the repertoire reveals recurrent, cryptic and hematopoietic HLA class I minor histocompatibility antigens. Blood (2024)
Jesper van Eck van der Sluijs, Diede van Ens, Jolanda Brummelman, Daan Heister, Aastha Sareen, Lisa Truijen, Dorette S van Ingen Schenau, Mirjam H M Heemskerk, Marieke Griffioen, Michel G D Kester, Nicolaas P M Schaap, Joop H Jansen, Anniek B van der Waart, Harry Dolstra, Willemijn Hobo
Human CD34 + -derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8 + T cell and NK cell responses in vitro and in vivo. Cellular and molecular life sciences : CMLS 80 (10) (2023)
Jonas Birkelund Nilsson, Saghar Kaabinejadian, Hooman Yari, Michel G D Kester, Peter van Balen, William H Hildebrand, Morten Nielsen
Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning. Science advances 9 (47) (2023)
Miranda H Meeuwsen, Anne K Wouters, Renate S Hagedoorn, Michel G D Kester, Dennis F G Remst, Dirk M van der Steen, Arnoud de Ru, Peter A van Veelen, Jamie Rossjohn, Stephanie Gras, J H Frederik Falkenburg, Mirjam H M Heemskerk
Cutting Edge: Unconventional CD8 + T Cell Recognition of a Naturally Occurring HLA-A*02:01-Restricted 20mer Epitope. Journal of immunology (Baltimore, Md. : 1950) 208 (8) (2022)
Sebastian Klobuch, Jia Jia Lim, Peter van Balen, Michel G D Kester, Wendy de Klerk, Arnoud H de Ru, Cilia R Pothast, Inge Jedema, Jan Wouter Drijfhout, Jamie Rossjohn, Hugh H Reid, Peter A van Veelen, J H Frederik Falkenburg, Mirjam H M Heemskerk
Human T cells recognize HLA-DP-bound peptides in two orientations. Proceedings of the National Academy of Sciences of the United States of America 119 (49) (2022)
Jesper van Eck van der Sluijs, Diede van Ens, Soley Thordardottir, Denise Vodegel, Inge A T Hermens, Anniek B van der Waart, J H Frederik Falkenburg, Michel G D Kester, Iris de Rink, Mirjam H M Heemskerk, Jannie Borst, Nicolaas P M Schaap, Joop H Jansen, Yanling Xiao, Harry Dolstra, Willemijn Hobo
Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses. Cancer immunology, immunotherapy : CII 70 (11) (2021)